<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32221807</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>02</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>02</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1573-742X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>49</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of thrombosis and thrombolysis</Title>
          <ISOAbbreviation>J Thromb Thrombolysis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Edoxaban affects TRAP-dependent platelet aggregation.</ArticleTitle>
        <Pagination>
          <StartPage>578</StartPage>
          <EndPage>583</EndPage>
          <MedlinePgn>578-583</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11239-020-02093-9</ELocationID>
        <Abstract>
          <AbstractText>Edoxaban is an oral anticoagulant drug and a direct factor Xa inhibitor. However, it is still not fully understood if and how edoxaban impacts platelet function. This prospective study aimed to assess in vitro platelet function in patients with atrial fibrillation (AF) receiving edoxaban. It was a single centre study quantifying platelet aggregation in 20 patients treated with edoxaban by light transmission aggregometry. The thrombin receptor activating peptide (TRAP)-induced platelet aggregation was significantly lower 2 h after taking edoxaban compared to baseline value (44.7 ± 32.03% vs. 73.3 ± 25.55%; p &lt; 0.0001). In addition, we did not find any significant difference in results between the patient groups.The TRAP-induced platelet aggregation is reduced in non-valvular AF patients receiving edoxaban.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nehaj</LastName>
            <ForeName>Frantisek</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>First Department of Internal Medicine, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59, Martin, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sokol</LastName>
            <ForeName>Juraj</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0003-2786-0505</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Haematology and Transfusion Medicine, National Centre of Haemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59, Martin, Slovakia. juraj.sokol@me.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ivankova</LastName>
            <ForeName>Jela</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Haematology and Transfusion Medicine, National Centre of Haemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59, Martin, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mokan</LastName>
            <ForeName>Michal</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>First Department of Internal Medicine, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59, Martin, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mokan</LastName>
            <ForeName>Marian</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Haematology and Transfusion Medicine, National Centre of Haemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59, Martin, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stasko</LastName>
            <ForeName>Jan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Haematology and Transfusion Medicine, National Centre of Haemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59, Martin, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Thromb Thrombolysis</MedlineTA>
        <NlmUniqueID>9502018</NlmUniqueID>
        <ISSNLinking>0929-5305</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D065427">Factor Xa Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013844">Thiazoles</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>NDU3J18APO</RegistryNumber>
          <NameOfSubstance UI="C552171">edoxaban</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065427" MajorTopicYN="N">Factor Xa Inhibitors</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010974" MajorTopicYN="N">Platelet Aggregation</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013844" MajorTopicYN="N">Thiazoles</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Aggregation</Keyword>
        <Keyword MajorTopicYN="N">Doacs</Keyword>
        <Keyword MajorTopicYN="N">Edoxaban</Keyword>
        <Keyword MajorTopicYN="N">Platelet</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32221807</ArticleId>
        <ArticleId IdType="doi">10.1007/s11239-020-02093-9</ArticleId>
        <ArticleId IdType="pii">10.1007/s11239-020-02093-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Thromb Haemost. 2003 Jul;1(7):1504-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12871286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Treat Options Cardiovasc Med. 2010 Jun;12(3):274-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20842548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Thromb Thrombolysis. 2016 Jan;41(1):32-67</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26780738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acta Biomater. 2018 Jun;73:228-235</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29654993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Haematol. 2011 Oct;155(1):30-44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21790527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol Ther. 2014 Sep;19(5):409-16</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24607764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Thromb Thrombolysis. 2016 Jan;41(1):206-32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26780747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Thromb Thrombolysis. 2015 Apr;39(3):288-94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25669624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2017 Oct 5;377(14):1319-1330</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28844192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am Fam Physician. 2018 Apr 15;97(8):529-530</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29671492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 1967 Dec 2;216(5118):857-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6074962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Appl Thromb Hemost. 2018 Sep;24(6):914-919</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29050502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Appl Thromb Hemost. 2018 Mar;24(2):268-272</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28703014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Thromb Haemost. 2015 Nov;13(11):1949-59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26386264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs Today (Barc). 2019 Mar;55(3):197-214</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30938374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blood. 1991 Feb 15;77(4):770-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1704263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 2000 Sep 14;407(6801):258-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11001069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blood. 2014 Sep 11;124(11):1705-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24869936</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
